DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-dysport and botox-assuming a ratio of 4:1
Identifieur interne :
003694 ( PascalFrancis/Curation );
précédent :
003693;
suivant :
003695
DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-dysport and botox-assuming a ratio of 4:1
Auteurs : C. Sampaio [
Portugal] ;
J. J. Ferreira [
Portugal] ;
F. Simoes [
Portugal] ;
M. J. Rosas [
Portugal] ;
M. Magalhaes [
Portugal] ;
A. P. Correia [
Portugal] ;
A. Bastos-Lima [
Portugal] ;
R. Martins [
Portugal] ;
A. Castro-Caldas [
Portugal]
Source :
-
Movement disorders [ 0885-3185 ] ; 1997.
RBID : Pascal:98-0015582
Descripteurs français
English descriptors
pA |
A01 | 01 | 1 | | @0 0885-3185 |
---|
A03 | | 1 | | @0 Mov. disord. |
---|
A05 | | | | @2 12 |
---|
A06 | | | | @2 6 |
---|
A08 | 01 | 1 | ENG | @1 DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-dysport and botox-assuming a ratio of 4:1 |
---|
A11 | 01 | 1 | | @1 SAMPAIO (C.) |
---|
A11 | 02 | 1 | | @1 FERREIRA (J. J.) |
---|
A11 | 03 | 1 | | @1 SIMOES (F.) |
---|
A11 | 04 | 1 | | @1 ROSAS (M. J.) |
---|
A11 | 05 | 1 | | @1 MAGALHAES (M.) |
---|
A11 | 06 | 1 | | @1 CORREIA (A. P.) |
---|
A11 | 07 | 1 | | @1 BASTOS-LIMA (A.) |
---|
A11 | 08 | 1 | | @1 MARTINS (R.) |
---|
A11 | 09 | 1 | | @1 CASTRO-CALDAS (A.) |
---|
A14 | 01 | | | @1 Institute of Pharmacology and General Therapeutics, Faculty of Medicine, University of Lisbon @2 Lisbon @3 PRT @Z 1 aut. |
---|
A14 | 02 | | | @1 Department of Neurology, Faculty of Medicine, Santa Maria Hospital and University of Lisbon @2 Lisbon @3 PRT @Z 2 aut. @Z 9 aut. |
---|
A14 | 03 | | | @1 Department of Neurology and Neurosurgery, S. Joao Hospital @2 Porto @3 PRT @Z 3 aut. @Z 8 aut. |
---|
A14 | 04 | | | @1 Department of Neurology, St. António Hospital Porto @3 PRT @Z 4 aut. @Z 5 aut. @Z 6 aut. @Z 7 aut. |
---|
A20 | | | | @1 1013-1018 |
---|
A21 | | | | @1 1997 |
---|
A23 | 01 | | | @0 ENG |
---|
A43 | 01 | | | @1 INIST @2 20953 @5 354000069474290250 |
---|
A44 | | | | @0 0000 @1 © 1997 INIST-CNRS. All rights reserved. |
---|
A45 | | | | @0 16 ref. |
---|
A47 | 01 | 1 | | @0 98-0015582 |
---|
A60 | | | | @1 P |
---|
A61 | | | | @0 A |
---|
A64 | | 1 | | @0 Movement disorders |
---|
A66 | 01 | | | @0 USA |
---|
C02 | 01 | X | | @0 002B02C |
---|
C03 | 01 | X | FRE | @0 Blépharospasme @5 01 |
---|
C03 | 01 | X | ENG | @0 Blepharospasm @5 01 |
---|
C03 | 01 | X | SPA | @0 Blefaroespasmo @5 01 |
---|
C03 | 02 | X | FRE | @0 Hémispasme facial @5 04 |
---|
C03 | 02 | X | ENG | @0 Hemifacial spasm @5 04 |
---|
C03 | 02 | X | SPA | @0 Hemiespasmo facial @5 04 |
---|
C03 | 03 | X | FRE | @0 Toxine @5 07 |
---|
C03 | 03 | X | ENG | @0 Toxin @5 07 |
---|
C03 | 03 | X | SPA | @0 Toxina @5 07 |
---|
C03 | 04 | X | FRE | @0 Clostridium botulinum @2 NS @5 08 |
---|
C03 | 04 | X | ENG | @0 Clostridium botulinum @2 NS @5 08 |
---|
C03 | 04 | X | SPA | @0 Clostridium botulinum @2 NS @5 08 |
---|
C03 | 05 | X | FRE | @0 Etude comparative @5 16 |
---|
C03 | 05 | X | ENG | @0 Comparative study @5 16 |
---|
C03 | 05 | X | GER | @0 Vergleich @5 16 |
---|
C03 | 05 | X | SPA | @0 Estudio comparativo @5 16 |
---|
C03 | 06 | X | FRE | @0 Traitement @5 17 |
---|
C03 | 06 | X | ENG | @0 Treatment @5 17 |
---|
C03 | 06 | X | GER | @0 Aufbereiten @5 17 |
---|
C03 | 06 | X | SPA | @0 Tratamiento @5 17 |
---|
C03 | 07 | X | FRE | @0 Homme @5 20 |
---|
C03 | 07 | X | ENG | @0 Human @5 20 |
---|
C03 | 07 | X | SPA | @0 Hombre @5 20 |
---|
C03 | 08 | X | FRE | @0 Chimiothérapie @5 23 |
---|
C03 | 08 | X | ENG | @0 Chemotherapy @5 23 |
---|
C03 | 08 | X | SPA | @0 Quimioterapia @5 23 |
---|
C03 | 09 | X | FRE | @0 Equivalence @5 24 |
---|
C03 | 09 | X | ENG | @0 Equivalence @5 24 |
---|
C03 | 09 | X | SPA | @0 Equivalencia @5 24 |
---|
C03 | 10 | X | FRE | @0 Forme pharmaceutique @5 35 |
---|
C03 | 10 | X | ENG | @0 Dosage form @5 35 |
---|
C03 | 10 | X | SPA | @0 Forma farmacéutica @5 35 |
---|
C07 | 01 | X | FRE | @0 Clostridiaceae @2 NS |
---|
C07 | 01 | X | ENG | @0 Clostridiaceae @2 NS |
---|
C07 | 01 | X | SPA | @0 Clostridiaceae @2 NS |
---|
C07 | 02 | X | FRE | @0 Clostridiales @2 NS |
---|
C07 | 02 | X | ENG | @0 Clostridiales @2 NS |
---|
C07 | 02 | X | SPA | @0 Clostridiales @2 NS |
---|
C07 | 03 | X | FRE | @0 Bactérie |
---|
C07 | 03 | X | ENG | @0 Bacteria |
---|
C07 | 03 | X | SPA | @0 Bacteria |
---|
C07 | 04 | X | FRE | @0 Oeil pathologie @5 37 |
---|
C07 | 04 | X | ENG | @0 Eye disease @5 37 |
---|
C07 | 04 | X | SPA | @0 Ojo patología @5 37 |
---|
C07 | 05 | X | FRE | @0 Paupière pathologie @5 38 |
---|
C07 | 05 | X | ENG | @0 Eyelid disease @5 38 |
---|
C07 | 05 | X | SPA | @0 Párpado patología @5 38 |
---|
C07 | 06 | X | FRE | @0 Système nerveux pathologie @5 45 |
---|
C07 | 06 | X | ENG | @0 Nervous system diseases @5 45 |
---|
C07 | 06 | X | SPA | @0 Sistema nervioso patología @5 45 |
---|
C07 | 07 | X | FRE | @0 Mouvement involontaire @5 46 |
---|
C07 | 07 | X | ENG | @0 Involuntary movement @5 46 |
---|
C07 | 07 | X | SPA | @0 Movimiento involuntario @5 46 |
---|
N21 | | | | @1 364 |
---|
|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003130
Links to Exploration step
Pascal:98-0015582
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-dysport and botox-assuming a ratio of 4:1</title>
<author><name sortKey="Sampaio, C" sort="Sampaio, C" uniqKey="Sampaio C" first="C." last="Sampaio">C. Sampaio</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute of Pharmacology and General Therapeutics, Faculty of Medicine, University of Lisbon</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Ferreira, J J" sort="Ferreira, J J" uniqKey="Ferreira J" first="J. J." last="Ferreira">J. J. Ferreira</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Neurology, Faculty of Medicine, Santa Maria Hospital and University of Lisbon</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>2 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Simoes, F" sort="Simoes, F" uniqKey="Simoes F" first="F." last="Simoes">F. Simoes</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology and Neurosurgery, S. Joao Hospital</s1>
<s2>Porto</s2>
<s3>PRT</s3>
<sZ>3 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Rosas, M J" sort="Rosas, M J" uniqKey="Rosas M" first="M. J." last="Rosas">M. J. Rosas</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Neurology, St. António Hospital Porto</s1>
<s3>PRT</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Magalhaes, M" sort="Magalhaes, M" uniqKey="Magalhaes M" first="M." last="Magalhaes">M. Magalhaes</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Neurology, St. António Hospital Porto</s1>
<s3>PRT</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Correia, A P" sort="Correia, A P" uniqKey="Correia A" first="A. P." last="Correia">A. P. Correia</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Neurology, St. António Hospital Porto</s1>
<s3>PRT</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Bastos Lima, A" sort="Bastos Lima, A" uniqKey="Bastos Lima A" first="A." last="Bastos-Lima">A. Bastos-Lima</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Neurology, St. António Hospital Porto</s1>
<s3>PRT</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Martins, R" sort="Martins, R" uniqKey="Martins R" first="R." last="Martins">R. Martins</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology and Neurosurgery, S. Joao Hospital</s1>
<s2>Porto</s2>
<s3>PRT</s3>
<sZ>3 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Castro Caldas, A" sort="Castro Caldas, A" uniqKey="Castro Caldas A" first="A." last="Castro-Caldas">A. Castro-Caldas</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Neurology, Faculty of Medicine, Santa Maria Hospital and University of Lisbon</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>2 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">98-0015582</idno>
<date when="1997">1997</date>
<idno type="stanalyst">PASCAL 98-0015582 INIST</idno>
<idno type="RBID">Pascal:98-0015582</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003130</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003694</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-dysport and botox-assuming a ratio of 4:1</title>
<author><name sortKey="Sampaio, C" sort="Sampaio, C" uniqKey="Sampaio C" first="C." last="Sampaio">C. Sampaio</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute of Pharmacology and General Therapeutics, Faculty of Medicine, University of Lisbon</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Ferreira, J J" sort="Ferreira, J J" uniqKey="Ferreira J" first="J. J." last="Ferreira">J. J. Ferreira</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Neurology, Faculty of Medicine, Santa Maria Hospital and University of Lisbon</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>2 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Simoes, F" sort="Simoes, F" uniqKey="Simoes F" first="F." last="Simoes">F. Simoes</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology and Neurosurgery, S. Joao Hospital</s1>
<s2>Porto</s2>
<s3>PRT</s3>
<sZ>3 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Rosas, M J" sort="Rosas, M J" uniqKey="Rosas M" first="M. J." last="Rosas">M. J. Rosas</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Neurology, St. António Hospital Porto</s1>
<s3>PRT</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Magalhaes, M" sort="Magalhaes, M" uniqKey="Magalhaes M" first="M." last="Magalhaes">M. Magalhaes</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Neurology, St. António Hospital Porto</s1>
<s3>PRT</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Correia, A P" sort="Correia, A P" uniqKey="Correia A" first="A. P." last="Correia">A. P. Correia</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Neurology, St. António Hospital Porto</s1>
<s3>PRT</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Bastos Lima, A" sort="Bastos Lima, A" uniqKey="Bastos Lima A" first="A." last="Bastos-Lima">A. Bastos-Lima</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Neurology, St. António Hospital Porto</s1>
<s3>PRT</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Martins, R" sort="Martins, R" uniqKey="Martins R" first="R." last="Martins">R. Martins</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology and Neurosurgery, S. Joao Hospital</s1>
<s2>Porto</s2>
<s3>PRT</s3>
<sZ>3 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Castro Caldas, A" sort="Castro Caldas, A" uniqKey="Castro Caldas A" first="A." last="Castro-Caldas">A. Castro-Caldas</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Neurology, Faculty of Medicine, Santa Maria Hospital and University of Lisbon</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>2 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1997">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Blepharospasm</term>
<term>Chemotherapy</term>
<term>Clostridium botulinum</term>
<term>Comparative study</term>
<term>Dosage form</term>
<term>Equivalence</term>
<term>Hemifacial spasm</term>
<term>Human</term>
<term>Toxin</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Blépharospasme</term>
<term>Hémispasme facial</term>
<term>Toxine</term>
<term>Clostridium botulinum</term>
<term>Etude comparative</term>
<term>Traitement</term>
<term>Homme</term>
<term>Chimiothérapie</term>
<term>Equivalence</term>
<term>Forme pharmaceutique</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA08 i1="01" i2="1" l="ENG"><s1>DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-dysport and botox-assuming a ratio of 4:1</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>SAMPAIO (C.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>FERREIRA (J. J.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SIMOES (F.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>ROSAS (M. J.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>MAGALHAES (M.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>CORREIA (A. P.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>BASTOS-LIMA (A.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>MARTINS (R.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>CASTRO-CALDAS (A.)</s1>
</fA11>
<fA14 i1="01"><s1>Institute of Pharmacology and General Therapeutics, Faculty of Medicine, University of Lisbon</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Neurology, Faculty of Medicine, Santa Maria Hospital and University of Lisbon</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>2 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neurology and Neurosurgery, S. Joao Hospital</s1>
<s2>Porto</s2>
<s3>PRT</s3>
<sZ>3 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Neurology, St. António Hospital Porto</s1>
<s3>PRT</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA20><s1>1013-1018</s1>
</fA20>
<fA21><s1>1997</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000069474290250</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1997 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>16 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>98-0015582</s0>
</fA47>
<fA64 i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02C</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Blépharospasme</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Blepharospasm</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Blefaroespasmo</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Hémispasme facial</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Hemifacial spasm</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Hemiespasmo facial</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Toxine</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Toxin</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Toxina</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Clostridium botulinum</s0>
<s2>NS</s2>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Clostridium botulinum</s0>
<s2>NS</s2>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Clostridium botulinum</s0>
<s2>NS</s2>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Etude comparative</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Comparative study</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="GER"><s0>Vergleich</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Estudio comparativo</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Traitement</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Treatment</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="GER"><s0>Aufbereiten</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>23</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>23</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>23</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Equivalence</s0>
<s5>24</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Equivalence</s0>
<s5>24</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Equivalencia</s0>
<s5>24</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Forme pharmaceutique</s0>
<s5>35</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Dosage form</s0>
<s5>35</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Forma farmacéutica</s0>
<s5>35</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Clostridiaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Clostridiaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Clostridiaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Clostridiales</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Clostridiales</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Clostridiales</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Bactérie</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Bacteria</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Bacteria</s0>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Oeil pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Eye disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Ojo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Paupière pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Eyelid disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Párpado patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>45</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>45</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>45</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>46</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>46</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>46</s5>
</fC07>
<fN21><s1>364</s1>
</fN21>
</pA>
</standard>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003694 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 003694 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:98-0015582
|texte= DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-dysport and botox-assuming a ratio of 4:1
}}
| This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 | ![](Common/icons/LogoDilib.gif) |